Price History:15.45%(TTM)
Over the latest trailing 12-month period, price cagr is +15.45%. The comparable SPY value is +20.96%. Year-to-date price return is +18.67%. Price CAGR uses adjusted close price history and excludes dividends.
Current Price
$206.24
+$3.13 (+1.54%)
Previous Close: $203.11
Last Session
- Open
- $203.14
- Day High
- $207.85
- Day Low
- $203.14
- Volume
- 632.40K
- Avg Volume
- 909.52K
52-Week Position
85%
of the 52-week price range
- From 52-week high
- -3.40%
- From 52-week low
- +25.26%
52-Week Price Range
52-Week Low
$164.65
Jul 15, 2025
Current Price
$206.24
85% of range
52-Week High
$213.50
Feb 27, 2026
Price Returns by Period
1 Day
+1.54%
7 Days
+5.76%
30 Days
+6.31%
YTD
+18.67%
1 Year
+16.48%
vs 52W High
-3.40%
DGX Price Chart
Long-Term Performance (CAGR)
Price CAGR (3Y)
+13.35%
Price CAGR (5Y)
+9.73%
Total Return CAGR (3Y)
+16.12%
Total Return CAGR (5Y)
+12.14%
CAGR (Compound Annual Growth Rate) shows the annualized return over the specified period. Total Return includes dividends reinvested.
Key Price Statistics
| Current Price | $206.24 |
| Previous Close | $203.11 |
| Day Range | $203.14 - $207.85 |
| 52-Week Range | $164.65 - $213.50 |
| Volume | 632.40K |
| Average Volume | 909.52K |
| Market Cap | $23.08B |
| % from 52W High | -3.40% |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis